# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-26-014687
Filing Date
2026-04-01
Accepted
2026-04-01 16:45:31
Documents
74
Period of Report
2025-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | form10-k.htm iXBRL | 10-K | 2446365
2 | EX-4.1 | ex4-1.htm | EX-4.1 | 28208
3 | EX-10.4 | ex10-4.htm | EX-10.4 | 21620
4 | EX-10.7 | ex10-7.htm | EX-10.7 | 21569
5 | EX-10.12 | ex10-12.htm | EX-10.12 | 21413
6 | EX-23.1 | ex23-1.htm | EX-23.1 | 4188
7 | EX-23.2 | ex23-2.htm | EX-23.2 | 4692
8 | EX-31.1 | ex31-1.htm | EX-31.1 | 11705
9 | EX-31.2 | ex31-2.htm | EX-31.2 | 11831
10 | EX-32.1 | ex32-1.htm | EX-32.1 | 8280
11 | EX-97.1 | ex97-1.htm | EX-97.1 | 75015
12 | GRAPHIC | form10-k_001.jpg | GRAPHIC | 50134
13 | GRAPHIC | form10-k_002.jpg | GRAPHIC | 16867
14 | GRAPHIC | form10-k_003.jpg | GRAPHIC | 9528
15 | GRAPHIC | form10-k_004.jpg | GRAPHIC | 3712
16 | GRAPHIC | ex23-2_001.jpg | GRAPHIC | 4914
| Complete submission text file | 0001493152-26-014687.txt |  | 9350364

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
17 | XBRL SCHEMA FILE | juns-20251231.xsd | EX-101.SCH | 55142
18 | XBRL CALCULATION FILE | juns-20251231_cal.xml | EX-101.CAL | 63546
19 | XBRL DEFINITION FILE | juns-20251231_def.xml | EX-101.DEF | 259747
20 | XBRL LABEL FILE | juns-20251231_lab.xml | EX-101.LAB | 517088
21 | XBRL PRESENTATION FILE | juns-20251231_pre.xml | EX-101.PRE | 392643
77 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-k_htm.xml | XML | 1179815

Mailing Address 1001 NORTH US HWY 1 SUITE 504 JUPITER FL 33477
Business Address 1001 NORTH US HWY 1 SUITE 504 JUPITER FL 33477 (561) 406-6154
JUPITER NEUROSCIENCES, INC. (Filer) CIK: 0001679628 (see all company filings)

EIN.: 474828381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41265 | Film No.: 26829041
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)